Literature DB >> 7698572

Meta-analysis of enteral nutrition as a primary treatment of active Crohn's disease.

A M Griffiths1, A Ohlsson, P M Sherman, L R Sutherland.   

Abstract

BACKGROUND/AIMS: The efficacy of enteral nutrition as primary therapy of active Crohn's disease is controversial. The aim of the study was to compare by meta-analysis the likelihood of clinical response to liquid diet therapy vs. corticosteroids and to assess the importance of formula composition to efficacy.
METHODS: Randomized controlled trials comparing exclusive enteral nutrition with corticosteroids and elemental with nonelemental formulas were identified through a combination of computerized and hand-searching techniques. Rates of clinical remission of active Crohn's disease, based on the intention-to-treat principle, were extracted from the studies by two independent reviewers. Odds ratios for likelihood of clinical response were calculated.
RESULTS: In eight trials comprising 413 patients, enteral nutrition was inferior to corticosteroids (pooled odds ratio, 0.35; 95% confidence interval, 0.23-0.53). In five trials comprising 134 patients, there was no difference in the efficacy of elemental versus nonelemental formulas (pooled odds ratio, 0.87; 95% confidence interval, 0.41-1.83).
CONCLUSIONS: Corticosteroids are more effective than enteral nutrition in the treatment of active Crohn's disease. Limited sample size precludes definitive conclusions about the importance of formula composition in the efficacy of enteral nutrition; however, data analyzed in this study do not support an advantage to elemental feedings compared with a polymeric formulation.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7698572     DOI: 10.1016/0016-5085(95)90203-1

Source DB:  PubMed          Journal:  Gastroenterology        ISSN: 0016-5085            Impact factor:   22.682


  53 in total

Review 1.  Management of Crohn's disease.

Authors:  D S Rampton
Journal:  BMJ       Date:  1999-12-04

2.  New treatments for inflammatory bowel disease.

Authors:  David S Rampton; D Phil
Journal:  World J Gastroenterol       Date:  1998-10       Impact factor: 5.742

3.  Management of difficult inflammatory bowel disease: where are we now?

Authors:  DS Rampton
Journal:  World J Gastroenterol       Date:  2000-06       Impact factor: 5.742

Review 4.  Clinical nutrition: 6. Management of nutritional problems of patients with Crohn's disease.

Authors:  Khursheed N Jeejeebhoy
Journal:  CMAJ       Date:  2002-04-02       Impact factor: 8.262

Review 5.  Therapy of Crohn's disease in childhood.

Authors:  R M Beattie
Journal:  Paediatr Drugs       Date:  2000 May-Jun       Impact factor: 3.022

6.  Polymeric formula has direct anti-inflammatory effects on enterocytes in an in vitro model of intestinal inflammation.

Authors:  Naomi S H de Jong; Steven T Leach; Andrew S Day
Journal:  Dig Dis Sci       Date:  2007-04-04       Impact factor: 3.199

Review 7.  To feed or not to feed? Are nutritional supplements worthwhile in active Crohn's disease?

Authors:  H Lochs
Journal:  Gut       Date:  2006-03       Impact factor: 23.059

8.  Does polymeric formula improve adherence to liquid diet therapy in children with active Crohn's disease?

Authors:  A F Rodrigues; T Johnson; P Davies; M S Murphy
Journal:  Arch Dis Child       Date:  2007-05-02       Impact factor: 3.791

Review 9.  Cost of illness of Crohn's disease.

Authors:  Keith Bodger
Journal:  Pharmacoeconomics       Date:  2002       Impact factor: 4.981

10.  Evidence-based clinical practice guidelines for Crohn's disease, integrated with formal consensus of experts in Japan.

Authors:  Fumiaki Ueno; Toshiyuki Matsui; Takayuki Matsumoto; Katsuyoshi Matsuoka; Mamoru Watanabe; Toshifumi Hibi
Journal:  J Gastroenterol       Date:  2012-10-23       Impact factor: 7.527

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.